The chemical class of α-actinin-4 activators comprises a diverse array of compounds that modulate the activation of α-actinin-4, a crucial regulator of actin cytoskeleton dynamics. These activators can be categorized into direct and indirect regulators, each exerting specific effects on the cellular pathways and mechanisms associated with α-actinin-4 function. Direct activators, including Blebbistatin and ML-7, impact myosin II, influencing actin-myosin interactions and indirectly modulating α-actinin-4 function in cytoskeletal organization.
Indirect activators, like Jasplakinolide influence α-actinin-4 by modulating actin dynamics. Jasplakinolide promotes actin polymerization, indirectly supporting α-actinin-4 activation. These compounds collectively highlight the intricate regulation of α-actinin-4 activation, showcasing the diverse array of pathways and processes involved in actin cytoskeleton dynamics. The chemical class emphasizes the importance of understanding the specific biochemical and cellular pathways influenced by each activator within this class. This knowledge is crucial for unraveling the complex network of interactions that govern α-actinin-4 activation and its role in maintaining proper cellular cytoskeletal organization. The activators, through their distinct mechanisms, provide valuable insights into potential strategies for modulating α-actinin-4 function, contributing to the understanding of cytoskeletal dynamics and their impact on cellular processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(±)-Blebbistatin | 674289-55-5 | sc-203532B sc-203532 sc-203532A sc-203532C sc-203532D | 5 mg 10 mg 25 mg 50 mg 100 mg | $183.00 $313.00 $464.00 $942.00 $1723.00 | 7 | |
Blebbistatin is a myosin II inhibitor that indirectly activates α-actinin-4 by affecting actin-myosin interactions. Inhibition of myosin II by Blebbistatin disrupts the contractile machinery, indirectly supporting α-actinin-4 activation. The compound influences actin-myosin dynamics, indirectly modulating α-actinin-4 function in cytoskeletal organization. Blebbistatin can alter cellular contractility, indirectly impacting α-actinin-4-mediated processes. | ||||||
Jasplakinolide | 102396-24-7 | sc-202191 sc-202191A | 50 µg 100 µg | $184.00 $305.00 | 59 | |
Jasplakinolide is an F-actin stabilizer that indirectly activates α-actinin-4 by promoting actin polymerization. Stabilization of F-actin by Jasplakinolide enhances actin filament formation, indirectly supporting α-actinin-4 activation. The compound impacts actin cytoskeleton dynamics, indirectly modulating α-actinin-4 function in cytoskeletal organization. Jasplakinolide can alter the architecture of actin filaments, indirectly impacting α-actinin-4-mediated cellular processes. | ||||||
ML-7 hydrochloride | 110448-33-4 | sc-200557 sc-200557A | 10 mg 50 mg | $91.00 $267.00 | 13 | |
ML-7 is a myosin light chain kinase (MLCK) inhibitor that indirectly activates α-actinin-4 by affecting myosin II activity. Inhibition of MLCK by ML-7 disrupts myosin II phosphorylation, indirectly supporting α-actinin-4 activation. The compound influences myosin II dynamics, indirectly modulating α-actinin-4 function in cytoskeletal organization. ML-7 can alter cellular contractility, indirectly impacting α-actinin-4-mediated processes. | ||||||